The Precision Medicine Project
The OCRF is excited to announce that we are now raising the funds needed to establish the Precision Medicine Project, which aims to offer women better treatment alternatives that are designed specifically for them.
Little progress has been made to improve chemotherapy options for women with ovarian cancer in the past 25 years. Ovarian cancers quickly develop drug resistance, meaning that while treatment may initially work, the cancer often fights back harder. A devastating 90% of women diagnosed at an advanced stage suffer a recurrence within two years of their initial treatment.
Now is the time to consider making a financial contribution. With the end of the financial year approaching, your tax-deductible donation before June 30 will help us raise the $100,000 urgently needed to establish and fund the OCRF’s Precision Medicine Project. Your gift will ensure women with ovarian cancer have access to the best possible treatment and help prevent disease drug resistance.
Funds raised as of 29th June: $74,270
The current state of ovarian cancer treatment
Women diagnosed with ovarian cancer today have few options available to them other than chemotherapy and radiotherapy treatment.
While chemotherapy was considered revolutionary when it was first introduced, little has changed over the past 25 years. Meanwhile, ovarian cancer has continued getting better at defending itself against drug treatments.
This is why treatment ‘success’ is often short lived. A devastating 90% of women diagnosed at an advanced stage suffer a recurrence within two years of completing their initial treatment.
Newer therapies, such as PARP inhibitors, are helpful in providing maintenance treatment for women with the BRCA gene, but this therapy is not available to the broader population.
Leane Flynn, OCRF Ambassador and long-time supporter of our work, knows the statistics all too well. In March of this year, she suffered her third ovarian cancer diagnosis since 2017.
How you can help
The OCRF is raising funds to establish The Precision Medicine Project, which aims to offer women better treatment alternatives that are designed specifically for them.
It will mean the disease has less opportunity to develop resistance. And it will mean more women survive ovarian cancer, beyond their immediate future.
How the Precision Medicine Project works
Under this project, doctors will test all available drugs against their patient’s cancer. They will note specifics about their patient, and measure both cancer response and patient effect.
This will help them to chart a specific, targeted treatment plan that will predict the changing nature of the disease to stay one step ahead of drug resistance.
And finally, we will establish a living biobank registry that captures this valuable data from individual patients, helping to tailor future treatments to women who have exhibited similar characteristics and responses.
Put simply, this initiative enables doctors working with women today to collaborate with researchers working for the future of medicine, collecting patient samples that will lay the foundations for the future of personalised treatment.
But without government funding, the OCRF relies on the support of our community to bring projects like this to life.
Please make a tax-deductible donation before June 30 to help us reach the needed $100,000 to establish the Precision Medicine Project and fund it beyond its first year.